Alexandria Seed Capital Platform
An innovative funding model catalyzing seed-stage investments in the most promising life science startups

The Alexandria Seed Capital Platform Advisory Board

The Alexandria Seed Capital Platform brings together leaders from across the life science community to catalyze seed-stage investment in the most promising life science startups. This unique platform will be led by Alexandria Venture Investments and supported by a preeminent Advisory Board of seasoned biopharma and venture capital executives from Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly and Company, Pfizer, and Roche.

Eligible Companies

Seed-stage investment opportunities are sourced directly from Alexandria LaunchLabs and the Alexandria national network. Sectors of interest include novel drug discovery platforms, diagnostics, medical technologies, and bioinformatics-driven healthcare solutions.


Selection Criteria

Funding decisions are made based on the quality and differentiation of a company’s technology, foundational IP, business strategy, financing plan, and management team.

Beyond Investment

With their deep experience in building and nurturing life science companies, Advisory Board members provide mentorship to entrepreneurs who receive funding through the platform. This high level of engagement is designed to increase the trajectory of recipient seed-stage companies and to lay a foundation for future investment and collaboration.

Through this unique platform, Alexandria aims to enhance the momentum around seed-stage life science investing and to attract new interest from traditional and non-traditional investors to funding opportunities that represent the promise of transformative discoveries in biomedicine.